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Introduction
Peripheral Arterial Disease (PAD) is significant issue in
the UK. Under diagnosis and management results in
avoidable heart attacks, strokes and amputations. Our
NHS organisation has commissioned a new Podiatry-
led, multidisciplinary, community-based, PAD service.
It is focussed on stimulating identification, diagnosis
and management, as part of an approach to address
poor local cardiovascular disease (CVD) outcomes. We
will outline the development and description of the
service model and present initial outcomes from it.
This will complement the key conference theme of
peripheral arterial disease, as presented by Prof. Cliff
Shearman.
Methods
We describe how we used best clinical evidence (SIGN,
2006) as a foundation for defining the clinical content
and pathways. The service specification outlined key
areas for delivery and progress reporting. We will give
an overview of our service development plan, which
has focussed on developing proactive initiatives
and outcomes in these areas, via broad stakeholder
engagement.
Results
Results on referral patterns, subsequent PAD diagnosis
& severity, treatment and patient satisfaction will be
presented.
Discussion
Discussion of the added value of this service within the
traditional NHS Podiatry / PAD / CVD service land-
scape will be presented, along with recommendations
for further strengthening the service model.
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